Literature DB >> 20800634

Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis.

Carlo Amorin Daep1, Elizabeth A Novak, Richard J Lamont, Donald R Demuth.   

Abstract

The interaction of the periodontal pathogen, Porphyromonas gingivalis, with oral streptococci such as Streptococcus gordonii precedes colonization of the subgingival pocket and represents a target for limiting P. gingivalis colonization of the oral cavity. Previous studies showed that a synthetic peptide (designated BAR) derived from the antigen I/II protein of S. gordonii was a potent competitive inhibitor of P. gingivalis adherence to S. gordonii and subsequent biofilm formation. Here we show that despite its inhibitory activity, BAR is rapidly degraded by intact P. gingivalis cells in vitro. However, in the presence of soluble Mfa protein, the P. gingivalis receptor for BAR, the peptide is protected from proteolytic degradation suggesting that the affinity of BAR for Mfa is higher than for P. gingivalis proteases. The rate of BAR degradation was reduced when the P. gingivalis lysine-specific gingipain was inhibited using the specific protease inhibitor, z-FKcK, or when the gene encoding the Lys-gingipain was inactivated. In addition, substituting d-Lys for l-Lys residues in BAR prevented degradation of the peptide when incubated with the Lys-gingipain and increased its specific adherence inhibitory activity in a S. gordonii-P. gingivalis dual species biofilm model. These results suggest that Lys-gingipain accounts in large part for P. gingivalis-mediated degradation of BAR and that more effective peptide inhibitors of P. gingivalis adherence to streptococci can be produced by introducing modifications that limit the susceptibility of BAR to the Lys-gingipain and other P. gingivalis associated proteases.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800634      PMCID: PMC2967622          DOI: 10.1016/j.peptides.2010.08.014

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  41 in total

Review 1.  Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire.

Authors:  N M O-Brien-Simpson; P D Veith; S G Dashper; E C Reynolds
Journal:  Curr Protein Pept Sci       Date:  2003-12       Impact factor: 3.272

2.  Role of gingipains in growth of Porphyromonas gingivalis in the presence of human serum albumin.

Authors:  D Grenier; S Imbeault; P Plamondon; G Grenier; K Nakayama; D Mayrand
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Discrete protein determinant directs the species-specific adherence of Porphyromonas gingivalis to oral streptococci.

Authors:  D R Demuth; D C Irvine; J W Costerton; G S Cook; R J Lamont
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Metabolic pathways for cytotoxic end product formation from glutamate- and aspartate-containing peptides by Porphyromonas gingivalis.

Authors:  N Takahashi; T Sato; T Yamada
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

5.  Identification of a Porphyromonas gingivalis receptor for the Streptococcus gordonii SspB protein.

Authors:  W O Chung; D R Demuth; R J Lamont
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis.

Authors:  M A Curtis; H K Kuramitsu; M Lantz; F L Macrina; K Nakayama; J Potempa; E C Reynolds; J Aduse-Opoku
Journal:  J Periodontal Res       Date:  1999-11       Impact factor: 4.419

7.  Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.

Authors:  Daniel Grenier; Sophie Roy; Fatiha Chandad; Pascale Plamondon; Masami Yoshioka; Koji Nakayama; Denis Mayrand
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Complete genome sequence of the oral pathogenic Bacterium porphyromonas gingivalis strain W83.

Authors:  Karen E Nelson; Robert D Fleischmann; Robert T DeBoy; Ian T Paulsen; Derrick E Fouts; Jonathan A Eisen; Sean C Daugherty; Robert J Dodson; A Scott Durkin; Michelle Gwinn; Daniel H Haft; James F Kolonay; William C Nelson; Tanya Mason; Luke Tallon; Jessica Gray; David Granger; Hervé Tettelin; Hong Dong; Jamie L Galvin; Margaret J Duncan; Floyd E Dewhirst; Claire M Fraser
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

9.  Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates.

Authors:  Richard J Lamont; Azza El-Sabaeny; Yoonsuk Park; Guy S Cook; J William Costerton; Donald R Demuth
Journal:  Microbiology       Date:  2002-06       Impact factor: 2.777

10.  Clinical findings in oral health during progression of chronic kidney disease to end-stage renal disease in a Swedish population.

Authors:  Royne Thorman; Martin Neovius; Britta Hylander
Journal:  Scand J Urol Nephrol       Date:  2009
View more
  7 in total

Review 1.  Antimicrobial Peptides: Mechanisms of Action and Resistance.

Authors:  B Bechinger; S-U Gorr
Journal:  J Dent Res       Date:  2016-11-25       Impact factor: 6.116

2.  Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity.

Authors:  Mahsa Abdolhosseini; Seshagiri R Nandula; Jonathan Song; Helmut Hirt; Sven-Ulrik Gorr
Journal:  Peptides       Date:  2012-03-28       Impact factor: 3.750

3.  Functional Advantages of Porphyromonas gingivalis Vesicles.

Authors:  Meng-Hsuan Ho; Chin-Ho Chen; J Shawn Goodwin; Bing-Yan Wang; Hua Xie
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

4.  Antibiofilm peptides against oral biofilms.

Authors:  Zhejun Wang; Ya Shen; Markus Haapasalo
Journal:  J Oral Microbiol       Date:  2017-06-14       Impact factor: 5.474

5.  Identification of functional domains of the minor fimbrial antigen involved in the interaction of Porphyromonas gingivalis with oral streptococci.

Authors:  Mohammad Roky; John O Trent; Donald R Demuth
Journal:  Mol Oral Microbiol       Date:  2020-02-13       Impact factor: 3.563

6.  Community Development between Porphyromonas gingivalis and Candida albicans Mediated by InlJ and Als3.

Authors:  Maryta N Sztukowska; Lindsay C Dutton; Christopher Delaney; Mark Ramsdale; Gordon Ramage; Howard F Jenkinson; Angela H Nobbs; Richard J Lamont
Journal:  MBio       Date:  2018-04-24       Impact factor: 7.867

Review 7.  Peptide and non-peptide mimetics as potential therapeutics targeting oral bacteria and oral biofilms.

Authors:  Maryta N Sztukowska; Mohammad Roky; Donald R Demuth
Journal:  Mol Oral Microbiol       Date:  2019-08-15       Impact factor: 3.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.